Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
After a series of setbacks, Republicans challenging the constitutionality of the Affordable Care Act (ACA) and its individual mandate are…
From - Laboratory Industry Report
Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from…
From - Laboratory Industry Report
After a slow August, product launches were up in volume but not dramatic impact. Here's a rundown of the new diagnostics to hit the market in…
From - Laboratory Industry Report
Artificial intelligence (AI) and machine learning are making significant inroads in the diagnostics realm. Here are four ways…
From - Laboratory Industry Report
The National Independent Laboratory Association's (NILA's) Opioid Task Force is releasing a white paper entitled…
From - Laboratory Industry Report
After a busy July, the pace and volume of new product launches slowed significantly in August…
From - Laboratory Industry Report
On Aug. 3, the Food and Drug Administration heated the long simmering controversy over FDA regulation of laboratory developed tests (LDTs) to full boil by submitting…